Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen
/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...
Source: prnewswire.com
Randall Carpenter News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Randall Carpenter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Randall Carpenter Today - Breaking & Trending Today
Allos Pharma Inc. Receives FDA Guidance for the Design of a Phase 3 Trial to Support a New Drug Application for Treatment of Fragile X Syndrome
/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...
Source: prnewswire.com
Rett Syndrome Research Trust Joins the Bespoke Gene Therapy Consortium
Trumbull, CT (PRWEB) February 03, 2022 -- The Rett Syndrome Research Trust (RSRT) has joined the Accelerating Medicines Partnership® Bespoke Gene Therapy
Source: prweb.com
Next-Generation Rett Syndrome Global Registry Designed to Unify Disparate Patient Data to Support Clinical Development Receives Positive Feedback from FDA
Trumbull, CT (PRWEB) January 18, 2022 -- The innovative Rett Syndrome Global Registry presented to the Food and Drug Administration (FDA) was met with
Source: prweb.com